Investor mix
8 investors on record; lead investors include Auriga Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Private equity | 1 | 13% |
| Other / undisclosed | 3 | 38% |
Developer of medicines for cancer, HIV, and opportunistic infections
8 investors on record; lead investors include Auriga Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Private equity | 1 | 13% |
| Other / undisclosed | 3 | 38% |